Related Experiment Video
Updated: Sep 23, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Novel MicroRNA-Regulated Transcript Networks Are Associated with Chemotherapy Response in Ovarian Cancer
Danai G Topouza1, Jihoon Choi1, Sean Nesdoly2
1Department of Biomedical and Molecular Sciences, Queen's University, 18 Stuart St., Kingston, ON K7L 3N6, Canada.
Abstract:
High-grade serous ovarian cancer (HGSOC) is a highly lethal gynecologic cancer, in part due to resistance to platinum-based chemotherapy reported among 20% of patients. This study aims to generate novel hypotheses of the biological mechanisms underlying chemotherapy resistance, which remain poorly understood. Differential expression analyses of mRNA- and microRNA-sequencing data from HGSOC patients of The Cancer Genome Atlas identified 21 microRNAs associated with angiogenesis and 196 mRNAs enriched for adaptive immunity and translation. Coexpression network analysis identified three microRNA networks associated with chemotherapy response enriched for lipoprotein transport and oncogenic pathways, as well as two mRNA networks enriched for ubiquitination and lipid metabolism. These network modules were replicated in two independent ovarian cancer cohorts. Moreover, integrative analyses of the mRNA/microRNA sequencing and single-nucleotide polymorphisms (SNPs) revealed potential regulation of significant mRNA transcripts by microRNAs and SNPs (expression quantitative trait loci). Thus, we report novel transcriptional networks and biological pathways associated with resistance to platinum-based chemotherapy in HGSOC patients. These results expand our understanding of the effector networks and regulators of chemotherapy response, which will help to improve the management of ovarian cancer.
Insights
Researchers identified novel microRNA and mRNA networks linked to platinum chemotherapy resistance in high-grade serous ovarian cancer (HGSOC). These findings offer new insights into ovarian cancer treatment resistance mechanisms.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- High-grade serous ovarian cancer (HGSOC) is a leading cause of cancer death.
- Platinum-based chemotherapy resistance affects 20% of HGSOC patients, highlighting an urgent need to understand underlying mechanisms.
Purpose of the Study:
- To uncover novel biological mechanisms and transcriptional networks driving chemotherapy resistance in HGSOC.
- To generate new hypotheses regarding the molecular basis of platinum resistance in ovarian cancer.
Main Methods:
- Differential expression analysis of mRNA and microRNA sequencing data from The Cancer Genome Atlas (TCGA) HGSOC cohort.
- Coexpression network analysis to identify key biological pathways and regulatory interactions.
- Replication of identified network modules in independent ovarian cancer patient cohorts.
- Integrative analysis of sequencing data with single-nucleotide polymorphisms (SNPs).
Main Results:
- Identified 21 microRNAs associated with angiogenesis and 196 mRNAs linked to adaptive immunity and translation.
- Discovered three microRNA networks (lipoprotein transport, oncogenic pathways) and two mRNA networks (ubiquitination, lipid metabolism) associated with chemotherapy response.
- Validated these network modules across independent cohorts.
- Revealed potential microRNA and SNP regulation of key mRNA transcripts.
Conclusions:
- Reported novel transcriptional networks and biological pathways implicated in platinum chemotherapy resistance in HGSOC.
- Expanded understanding of the molecular effectors and regulators influencing chemotherapy response in ovarian cancer.
- Findings provide a foundation for improving ovarian cancer management strategies.
Related Concept Videos
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

